US Bancorp DE trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 11.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,572 shares of the company’s stock after selling 7,772 shares during the quarter. US Bancorp DE’s holdings in Henry Schein were worth $4,373,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. BlackRock Inc. grew its holdings in Henry Schein by 2.4% in the first quarter. BlackRock Inc. now owns 11,389,688 shares of the company’s stock worth $684,635,000 after purchasing an additional 271,586 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Henry Schein by 9.8% during the second quarter. JPMorgan Chase & Co. now owns 2,664,995 shares of the company’s stock valued at $184,285,000 after buying an additional 238,078 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Henry Schein by 8.3% during the fourth quarter. Geode Capital Management LLC now owns 2,105,314 shares of the company’s stock valued at $165,038,000 after buying an additional 161,542 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Henry Schein by 1.1% during the second quarter. Northern Trust Corp now owns 1,959,014 shares of the company’s stock valued at $136,934,000 after buying an additional 20,415 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Henry Schein by 0.5% during the second quarter. Bank of New York Mellon Corp now owns 1,516,175 shares of the company’s stock valued at $105,980,000 after buying an additional 7,657 shares during the last quarter.
Shares of HSIC traded up $0.66 during trading hours on Thursday, reaching $63.53. 22,160 shares of the stock traded hands, compared to its average volume of 1,081,365. The company has a current ratio of 1.70, a quick ratio of 0.95 and a debt-to-equity ratio of 0.33. The stock has a fifty day simple moving average of $62.64 and a 200 day simple moving average of $64.62. Henry Schein, Inc. has a 52 week low of $56.58 and a 52 week high of $72.81. The company has a market cap of $9.65 billion, a price-to-earnings ratio of 15.36, a PEG ratio of 2.52 and a beta of 0.86.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.84 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.01. Henry Schein had a net margin of 4.18% and a return on equity of 16.67%. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.48 billion. During the same period last year, the firm earned $1.04 earnings per share. The firm’s revenue was up 5.7% on a year-over-year basis. Analysts predict that Henry Schein, Inc. will post 3.46 earnings per share for the current fiscal year.
In related news, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $60.17, for a total transaction of $412,525.52. Following the transaction, the insider now directly owns 249,046 shares of the company’s stock, valued at $14,985,097.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.06% of the stock is owned by company insiders.
A number of research analysts have recently issued reports on HSIC shares. TheStreet cut shares of Henry Schein from a “b” rating to a “c+” rating in a report on Friday, August 30th. William Blair cut shares of Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 7th. Barrington Research reiterated a “buy” rating and set a $75.00 price objective on shares of Henry Schein in a report on Wednesday, August 7th. Wolfe Research started coverage on shares of Henry Schein in a report on Thursday, May 30th. They set an “underperform” rating for the company. Finally, BidaskClub upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, September 12th. Six equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $73.64.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Relative Strength Index
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.